{"id":"W2245390479","doi":"10.1155/2006/876252","title":"Alemtuzumab and Natalizumab: The Monoclonal Antibody Story Continues","year":2006,"lang":"en","type":"article","venue":"Canadian Journal of Infectious Diseases and Medical Microbiology","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Natalizumab; Alemtuzumab; Medicine; Daclizumab; Monoclonal antibody; Adalimumab; Infliximab; Immunology; Monoclonal antibody therapy; Transplantation; Monoclonal; Hematopoietic stem cell transplantation; Disease; Antibody; Multiple sclerosis; Internal medicine; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001517988,0.0001305217,0.000306068,0.0001548107,0.0002292884,0.00002427491,0.00007198462,0.0001650588,0.0002305286],"category_scores_gemma":[0.0002851691,0.00007788858,0.0001133824,0.00006925723,0.0009084333,0.0000409485,0.0000169061,0.0003460692,0.000003194349],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006790308,"about_ca_system_score_gemma":0.001462441,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004760918,"about_ca_topic_score_gemma":0.00326937,"domain_scores_codex":[0.9991526,0.00009024046,0.0002696133,0.0001288024,0.00007463746,0.0002841302],"domain_scores_gemma":[0.998524,0.0001338337,0.0001237745,0.00008469471,0.0001044289,0.001029326],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003244915,0.0002735206,0.8820771,0.0001614324,0.0007178452,0.00476555,0.0001804644,0.0000042122,0.005490175,0.002940544,0.0732081,0.02985658],"study_design_scores_gemma":[0.004825959,0.0009176404,0.6415429,0.0003943165,0.0007874258,0.02954092,0.0001854376,0.00002606946,0.00006674268,0.0008273499,0.3206288,0.0002564323],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9343029,0.06168193,0.00001960394,0.002924362,0.0003892987,0.00009879271,0.0001029402,0.000009012632,0.0004711277],"genre_scores_gemma":[0.9967354,0.001185202,0.000005571696,0.00141805,0.0004407175,0.000001559669,0.00003380837,0.00001102396,0.0001686832],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2474207,"threshold_uncertainty_score":0.7197116,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.003049635077120726,"score_gpt":0.2267193224542835,"score_spread":0.2236696873771628,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}